A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million

5,000 shares were sold on June 1, 2026 for a total of approximately $1.14 million, at a weighted average price of about $227.06 per share. The article is a factual insider-sale disclosure with no accompanying operational or fundamental update. Market impact is likely limited unless the sale is part of a broader insider-trading pattern.

Analysis

5,000 shares were sold on June 1, 2026 for a total of approximately $1.14 million, at a weighted average price of about $227.06 per share. The article is a factual insider-sale disclosure with no accompanying operational or fundamental update. Market impact is likely limited unless the sale is part of a broader insider-trading pattern.